Associated adverse outcomes with tumor treating fields when combined to temozolomide versus temozolomide alone for the treatment of glioblastoma: a meta-analysis of randomized trials
Abstract Background Glioma is a brain tumor and glioblastoma represents its most common type, accounting for almost 40% of primary tumors of the central nervous system, and is associated with the worst prognosis. Glioblastoma remains one of the major challenges in neurooncology. Recently, the Food a...
Saved in:
Main Authors: | Yuanyuan Chen, Yan Chen, Hong Zhen, Danhua Lou |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2025-02-01
|
Series: | Egyptian Journal of Neurosurgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41984-025-00342-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protein kinase inhibitors as targeted therapy for glioblastoma: a meta-analysis of randomized controlled clinical trials
by: José Pinto-Fraga, et al.
Published: (2025-02-01) -
Identification and validation of TSPAN13 as a novel temozolomide resistance-related gene prognostic biomarker in glioblastoma.
by: Haofei Wang, et al.
Published: (2025-01-01) -
LAMB1 downregulation suppresses glioma progression by inhibiting aerobic glycolysis through regulation of the NF-κB/HK2 axis
by: Zhenxiang Zhao, et al.
Published: (2025-02-01) -
Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment.
by: Artem Berezovsky, et al.
Published: (2025-01-01) -
Near-infrared light triggered in situ release of CO for enhanced therapy of glioblastoma
by: Juan Ge, et al.
Published: (2023-02-01)